Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.
GlobalData on MSN17h
Abbott’s Amplatzer Amulet shows promise in atrial fibrillation trialAbbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) ...
Medpage Today on MSN22h
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years(JAMA Cardiology) Five-year results from the Amulet IDE trial suggested similar performance of the Amulet and Watchman 2.5 ...
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Footage of a man being shoved into a wall by a police officer before being dragged through a front yard has been shared on social media, with SA Police confirming a formal complaint has been made ...
Politics to sports, entertainment to business - Latest news from India and around the world on these topics and more LIVE on NDTV 24*7 ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback